Abstract
Neoplasms have been the leading cause of most deaths recorded annually worldwide. Scientists are engaged in research to continuously improve the treatment of the most diverse types of cancer. Therefore, the main objective of this project is to optimize the performance of the drug candidate LASSBio-1735, both through the development of new crystalline forms and through its controlled relea…